As of 2026-09-29, the Relative Valuation of Vir Biotechnology Inc (VIR) is (17.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.51 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -266.3%.
The range of the Relative Valuation is (15.75) - (18.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 27.7x | 22.9x |
| Forward P/E multiples | 21.1x - 25.2x | 23.9x |
| Fair Price | (15.75) - (18.85) | (17.48) |
| Upside | -249.8% - -279.4% | -266.3% |
| Date | P/E |
| 2026-09-28 | -14.07 |
| 2026-09-25 | -14.27 |
| 2026-09-24 | -14.35 |
| 2026-09-23 | -14.85 |
| 2026-09-22 | -15.39 |
| 2026-09-21 | -14.56 |
| 2026-09-18 | -14.19 |
| 2026-09-17 | -14.62 |
| 2026-09-16 | -14.08 |
| 2026-09-15 | -13.98 |
| 2026-09-14 | -14.41 |
| 2026-09-11 | -14.22 |
| 2026-09-10 | -14.16 |
| 2026-09-09 | -14.47 |
| 2026-09-08 | -14.97 |
| 2026-09-04 | -15.24 |
| 2026-09-03 | -15.33 |
| 2026-09-02 | -15.39 |
| 2026-09-01 | -15.57 |
| 2026-08-31 | -14.64 |
| 2026-08-28 | -14.50 |
| 2026-08-27 | -15.14 |
| 2026-08-26 | -14.83 |
| 2026-08-25 | -14.34 |
| 2026-08-24 | -13.27 |
| 2026-08-21 | -13.09 |
| 2026-08-20 | -12.33 |
| 2026-08-19 | -13.08 |
| 2026-08-18 | -12.70 |
| 2026-08-17 | -12.57 |
| 2026-08-14 | -12.37 |
| 2026-08-13 | -12.05 |
| 2026-08-12 | -11.99 |
| 2026-08-11 | -11.95 |
| 2026-08-10 | -11.90 |
| 2026-08-07 | -11.81 |
| 2026-08-06 | -11.73 |
| 2026-08-05 | -12.20 |
| 2026-08-04 | -12.28 |
| 2026-08-03 | -11.91 |
| 2026-07-31 | -11.59 |
| 2026-07-30 | -11.91 |
| 2026-07-29 | -11.57 |
| 2026-07-28 | -11.85 |
| 2026-07-27 | -11.78 |
| 2026-07-24 | -11.63 |
| 2026-07-23 | -12.50 |
| 2026-07-22 | -12.52 |
| 2026-07-21 | -12.61 |
| 2026-07-20 | -12.36 |